ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Hyloris Pharmaceuticals Sa

Hyloris Pharmaceuticals Sa (0AB6)

0.00
0.00
( 0.00% )

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
-
Bid
0.00
Offer
0.00
Volume
1
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
0.00
Open
-
Last Trade
1
@
5.24
(O)
Last Trade Time
19:00:06
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
28,000,000
Dividend Yield
-
PE Ratio
-9.54
Earnings Per Share (EPS)
-0.55
Revenue
4.21M
Net Profit
-15.38M

About Hyloris Pharmaceuticals Sa

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Liege, Liege, Bel
Founded
-
Hyloris Pharmaceuticals Sa is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0AB6. The last closing price for Hyloris Pharmaceuticals was 0.00 €. Over the last year, Hyloris Pharmaceuticals shares have traded in a share price range of 0.00 € to 0.00 €.

Hyloris Pharmaceuticals currently has 28,000,000 shares in issue. Hyloris Pharmaceuticals has a price to earnings ratio (PE ratio) of -9.54.

0AB6 Latest News

Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives

Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives Le total des produits et autres revenus atteint 4,4...

Hyloris Reports Full Year Results for 2023 & Provides Business Outlook

Hyloris Reports Full Year Results for 2023 & Provides Business Outlook Hyloris Reports Full Year Results for 2023 & Provides Business Outlook Total revenue and other income amounted to...

Communication at the request of the FSMA on the transactions with Qliniq

Communication at the request of the FSMA on the transactions with Qliniq Communication at the request of the FSMA on the transactions with Qliniq Revision of 2022 and half-year of 2023 (HY 2023...

Communiqué à la requête de la FSMA sur les transactions avec QliniQ

Communiqué à la requête de la FSMA sur les transactions avec QliniQ Communiqué à la requête de la FSMA sur les transactions avec QliniQ Retraitement des états financiers de 2022 et de juin 2023...

Hyloris Annonce ses Résultats Financiers Annuels le 14 mars 2024

Hyloris Annonce ses Résultats Financiers Annuels le 14 mars 2024 Liège, Belgique – le 8 mars 2024, 07:00 heures CET - Information non réglementée - Hyloris Pharmaceuticals SA (Euronext Bruxelles :...

Hyloris to Report 2023 Full-Year Results on 14 March 2024

Hyloris to Report 2023 Full-Year Results on 14 March 2024 Liège, Belgium – 08 February 2024, 07:00 AM CET – Non-regulated information – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a...

Hyloris Annonce le Lancement de Maxigesic® IV aux Etats-Unis ainsi que son Approbation au Canada

Hyloris Annonce le Lancement de Maxigesic® IV aux Etats-Unis ainsi que son Approbation au Canada Hyloris Annonce le Lancement de Maxigesic® IV aux Etats-Unis ainsi que son Approbation au Canada...

Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada

Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada Maxigesic® IV, a Potent Non-opioid...

Hyloris Enrolls First Patient in Phase 3 Clinical Trial for its Proprietary Mouth Rinse to Control Incidences of Bleeding Related to Dental Procedures

Hyloris Enrolls First Patient in Phase 3 Clinical Trial for its Proprietary Mouth Rinse to Control Incidences of Bleeding Related to Dental Procedures Innovative oral care solution aims to benefit...

Hyloris Recrute un Premier Patient dans le Cadre d'un Essai Clinique de Phase 3 portant sur son Rince-Bouche Breveté Destiné à Contrôler les Saignements lors des Interventions Dentaires

Hyloris Recrute un Premier Patient dans le Cadre d'un Essai Clinique de Phase 3 portant sur son Rince-Bouche Breveté Destiné à Contrôler les Saignements lors des Interventions Dentaires Une...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

0AB6 - Frequently Asked Questions (FAQ)

What is the current Hyloris Pharmaceuticals share price?
The current share price of Hyloris Pharmaceuticals is 0.00 €
How many Hyloris Pharmaceuticals shares are in issue?
Hyloris Pharmaceuticals has 28,000,000 shares in issue
What is the 1 year trading range for Hyloris Pharmaceuticals share price?
Hyloris Pharmaceuticals has traded in the range of 0.00 € to 0.00 € during the past year
What is the PE ratio of Hyloris Pharmaceuticals?
The price to earnings ratio of Hyloris Pharmaceuticals is -9.54
What is the cash to sales ratio of Hyloris Pharmaceuticals?
The cash to sales ratio of Hyloris Pharmaceuticals is 34.82
What is the reporting currency for Hyloris Pharmaceuticals?
Hyloris Pharmaceuticals reports financial results in EUR
What is the latest annual turnover for Hyloris Pharmaceuticals?
The latest annual turnover of Hyloris Pharmaceuticals is EUR 4.21M
What is the latest annual profit for Hyloris Pharmaceuticals?
The latest annual profit of Hyloris Pharmaceuticals is EUR -15.38M
What is the registered address of Hyloris Pharmaceuticals?
The registered address for Hyloris Pharmaceuticals is BOULEVARD PATIENCE ET BEAUJONC, LIEGE, LIEGE, 4000
What is the Hyloris Pharmaceuticals website address?
The website address for Hyloris Pharmaceuticals is www.hyloris.com
Which industry sector does Hyloris Pharmaceuticals operate in?
Hyloris Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SYMESupply@me Capital Plc
0.0025p
(38.89%)
612.94M
SCGLSealand Capital Galaxy Limited
3.00p
(20.00%)
21.7M
HE1Helium One Global Ltd
1.025p
(19.19%)
161.97M
INSGInsig Ai Plc
15.00p
(15.38%)
25.89k
CIZCizzle Biotechnology Holdings Plc
1.90p
(15.15%)
3.45M
TASTTasty Plc
0.65p
(-23.53%)
246.74k
EUAEurasia Mining Plc
4.90p
(-21.29%)
78.2M
LLAILunglife Ai Inc
1.85p
(-17.78%)
668.97k
PPSProton Motor Power Systems Plc
0.125p
(-16.67%)
640.84k
NOGNostrum Oil & Gas Plc
2.51p
(-15.91%)
818
NTVONativo Resources Plc
0.0015p
(0.00%)
734.47M
ORCPOracle Power Plc
0.0185p
(-6.57%)
680.58M
SYMESupply@me Capital Plc
0.0025p
(38.89%)
612.94M
EMEEmpyrean Energy Plc
0.155p
(-7.46%)
405.68M
MSMNMosman Oil And Gas Limited
0.0375p
(-2.60%)
244.79M

Discussion

View Full Feed
georgie18 georgie18 24 seconds ago
STI...3994...🥳...DALLAS, Feb. 11, 2025 /PRNewswire/ -- Solidion Technology, Inc. (NASDAQ: STI), an advanced battery technology solutions provider, today announced that its technical team has filed several US patent applications on an innovative process for cost-effective production of graphe
STI
MartinLutherKing MartinLutherKing 53 seconds ago
Beyond the $500B Stargate Project: The frontier of AI in oncology beckons

https://cancerletter.com/guest-editorial/20250124_3/#:~:text=This%20groundbreaking%20privately%20funded%20initiative,focus%20on%20%E2%80%9Ccuring%20cancer.%E2%80%9D
RNAZ
Tree Tree 1 minute ago
Good morning my little snow storms
KIPK KIPK 2 minutes ago
jondoeuk. Moral and ethical corruption applies well to you who have been constantly bashing NWBO because of your fear that Their Success Could destroy your investments...

KARMA upon you....

P.S. Your constant support of paid bashers on that MB is laughable...
NWBO
gedi8 gedi8 2 minutes ago
no problem
NXPL
DimesForShares DimesForShares 3 minutes ago
I appreciate the care with which you review these forms and report on deletions.  The conclusion that KBLB is no longer pretending to be on an uplist trajectory is inescapable.

I suppose we can celebrate the fact that Thompson finally recognizes an uplist is not in KBLB's near-term fu
KBLB
arachnodude arachnodude 3 minutes ago
Wow! Could you imagine the meltdowns if KBLB never included a Forward-Looking Statement disclaimer?! 🤯

💀 “You mean… businesses set targets… and sometimes adjust them?!”
💀 “Wait, so PRs aren’t contracts guaranteeing exact timelines?!”
💀 “Yo
KBLB
winstocksnew winstocksnew 4 minutes ago
Notes and Going concerns are troubling but you never know.
ABQQ
oystersnbeer oystersnbeer 4 minutes ago
DEM's lost the election
Is why you’re F’kd.
https://i.imgflip.com/9jq6v2.jpg
Seminole Red Seminole Red 4 minutes ago
This is quite a list

We got a DOGE staff list. From a McKinsey alum to a former Clarence Thomas clerk, here are the workers powering Elon Musk's cost-cutting squad.

https://www.msn.com/en-us/news/politics/we-got-a-doge-staff-list-from-a-mckinsey-alum-to-a-former-clarenc
work-n-hard work-n-hard 6 minutes ago
To your question: That doesn't seem to be the case at this time.
You might have missed that link at the end of Hogwart's post.

https://investorshub.advfn.com/uimage/uploads/2025/2/10/icihfI_have_no_proof.png

https://investorshub.advfn.com/boards/read_msg.aspx?mes
TSOI
uranium-pinto-beans uranium-pinto-beans 7 minutes ago
Todays Largest Increases in stock option open interest $MRK $NVDA $SMCI $BBAI $PLUG $TSLA $LCID $CLF $UBER
BBAI CLF LCID
Seminole Red Seminole Red 8 minutes ago
Susan Collins supports Kennedy.....more to follow
georgie18 georgie18 8 minutes ago
Nice News...🥳
Hopeforthefuture3 Hopeforthefuture3 8 minutes ago
Really no one believes much of anything you post. I have been heavily long for a decade and expected much better performance from management
Thankfully I have a relatively diverse portfolio that has overcome the decline in nwbo but still a lot of nwbo and a great opportunity cost given what
NWBO
Invest-in-America Invest-in-America 8 minutes ago
OCEA: Time to cash-in your proverbial casino chips here REAL QUICK, Homeboy!!! (Like, AI-QUANTUM-PARADIGM-SHIFT-QUICK !!! If not sooner.)
OCEA
DimesForShares DimesForShares 9 minutes ago
Webslinger's post of an article describing the yield of spun silk from a given weight of cocoons at 10% seems to be the most accurate way of estimating how much silk KBLB will receive from 1,200 pounds of cocoons.  It works out to be 55 or so kilos.  The mistake both you and I made was not recognizi
KBLB
MartinLutherKing MartinLutherKing 9 minutes ago
Cancer Cure moment on the world stage brother🚀🚀🚀🚀
RNAZ
georgie18 georgie18 9 minutes ago
Good Morning...🥳
scortech scortech 9 minutes ago
If you think retail traders want your kind of liquidity is the same thinking that keeps you sitting at the bus stop.
CGAC
Fdc4 Fdc4 10 minutes ago
Really? Under Donald Trump government you expect this to happen…. Like I said, always on the wrong path…. Apple would look at a stronger partnership or safer!!! Deepseek, why?

Baby steps mate, baby steps, then, learn how to crawl…. Pumpers
IGPK
Pokerpro05 Pokerpro05 10 minutes ago
https://ih.advfn.com/stock-market/USOTC/ab-pk-ABQQ/stock-news/95408750/form-424b3-prospectus-rule-424b3

Pokerpro05
ABQQ
georgie18 georgie18 11 minutes ago
Lol...🥳one is enough...thanks...
Here Today Here Today 11 minutes ago
Short SQUEEZE CENTRAL!!!!
RNAZ
Jasbg Jasbg 12 minutes ago
.
AMRN

Your Recent History

Delayed Upgrade Clock